These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 34275963)
1. Frequent Premature Ventricular Contraction and Non-Sustained Ventricular Tachycardia After the SARS-CoV-2 Vaccination in Patient With Implantable Cardioverter Defibrillator Due to Acquired Long-QT Syndrome. Aiba T; Ishibashi K; Hattori K; Wada M; Ueda N; Miyazaki Y; Wakamiya A; Yamagata K; Inoue Y; Miyamoto K; Nagase S; Kusano K Circ J; 2021 Oct; 85(11):2117. PubMed ID: 34275963 [No Abstract] [Full Text] [Related]
2. Proarrhythmic effect of pacing mode reprogramation in a patient with a congenital long-QT syndrome. Di Cori A; Zucchelli G; Romano S; Bongiorni MG J Cardiovasc Electrophysiol; 2013 Nov; 24(11):1304-5. PubMed ID: 23758507 [No Abstract] [Full Text] [Related]
3. Repetitive shock therapy of subcutaneous implantable cardioverter defibrillators in a patient with idiopathic ventricular fibrillation: What is the mechanism? Hasegawa K; Miyazaki S; Ishikawa E; Mukai M; Aoyama D; Nodera M; Kaseno K; Tada H J Cardiovasc Electrophysiol; 2019 Oct; 30(10):2121-2124. PubMed ID: 31332856 [No Abstract] [Full Text] [Related]
4. Ventricular arrhythmias after leadless pacemaker implantation, a case report and systematic review of the literature. Aparisi Á; Sandín-Fuentes M; García-Granja PE; García-Morán E; Rubio J J Cardiovasc Electrophysiol; 2020 Jan; 31(1):227-228. PubMed ID: 31808227 [No Abstract] [Full Text] [Related]
5. MY APPROACH to the patient with ventricular arrhythmia and no structural heart disease. Issa ZF Trends Cardiovasc Med; 2019 Apr; 29(3):190. PubMed ID: 30814035 [No Abstract] [Full Text] [Related]
6. Left cardiac sympathetic denervation in the management of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: A meta-regression. Sgrò A; Drake TM; Lopez-Ayala P; Phan K Congenit Heart Dis; 2019 Nov; 14(6):1102-1112. PubMed ID: 31621201 [TBL] [Abstract][Full Text] [Related]
7. RE: Clinical implication of detected tachyarrhythmias in patients with implantable cardioverter defibrillators. Ojo A; Goldenberg I J Cardiovasc Electrophysiol; 2024 Jul; 35(7):1517. PubMed ID: 38736193 [No Abstract] [Full Text] [Related]
8. Multiple ICD shocks in a patient with dilated cardiomyopathy: What is the mechanism? Fontenla A; López-Gil M; Rodríguez Muñoz D; Díez de Las Heras D; Arribas F J Cardiovasc Electrophysiol; 2019 May; 30(5):781-784. PubMed ID: 30688386 [TBL] [Abstract][Full Text] [Related]
9. Inappropriate implantable cardioverter-defibrillator therapy during exercise: what is the mechanism? Vollmann D; Lüthje L; Zabel M Heart Rhythm; 2009 May; 6(5):718-9. PubMed ID: 19303370 [No Abstract] [Full Text] [Related]
10. Clinical implication of detected tachyarrhythmias in patients with implantable cardioverter defibrillators. Kataoka N; Imamura T J Cardiovasc Electrophysiol; 2024 Jul; 35(7):1516. PubMed ID: 38708433 [No Abstract] [Full Text] [Related]
11. An unusual indication for subcutaneous implantable -cardioverter/defibrillator. De Schryver N; van Ruyssevelt C; Capulzini L Acta Cardiol; 2017 Aug; 72(4):487-488. PubMed ID: 28705110 [No Abstract] [Full Text] [Related]